Evidence map›Paper›PMID 33796482›Full record

ArticleFrontiers in cellular and infection microbiology2021

Identification of Microbiome Etiology Associated With Drug Resistance in Pleural Empyema.

Zhaoyan Chen, Hang Cheng, Zhao Cai, Qingjun Wei, Jinlong Li, Jinhua Liang, Wenshu Zhang, Zhijian Yu, Dongjing Liu, Lei Liu and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Rapid diagnosis ofFrontiers in cellular and infection microbiology · 2022
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. DNase inhibits early biofilm formation inFrontiers in cellular and infection microbiology · 2022
    Article
  17. Article
  18. The diagnostic value of metagenomic next-generation sequencing for identifyingFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Zhaoyan ChenIntensive Care Unit, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Hang ChengSchool of Medicine, Southern University of Science and Technology, Shenzhen, China.
Zhao CaiSchool of Medicine, Southern University of Science and Technology, Shenzhen, China.
Qingjun WeiDepartment of Orthopedic Trauma and Hand Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Jinlong LiPulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Jinhua LiangPulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Wenshu ZhangPulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Zhijian YuDepartment of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infection, Shenzhen Nanshan People's Hospital of Shenzhen University, Shenzhen, China.
Dongjing LiuNational Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, China.
Lei LiuNational Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, China.
Zhenqiang ZhangDepartment of Respiratory and Critical Care Medicine, Liuzhou People's Hospital, Liuzhou, China.
Ke WangPulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Liang YangSchool of Medicine, Southern University of Science and Technology, Shenzhen, China.
First Affiliated Hospital of GuangXi Medical University · CNSouthern University of Science and Technology · CNGuangxi Medical University · CNLiuzhou General Hospital · CNShenzhen Third People’s Hospital · CNShenzhen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identification of the offending organism and appropriate antimicrobial therapy are crucial for treating empyema. Diagnosis of empyema is largely obscured by the conventional bacterial cultivation and PCR process that has relatively low sensitivity, leading to limited understanding of the etiopathogenesis, microbiology, and role of antibiotics in the pleural cavity. To expand our understanding of its pathophysiology, we have carried out a metagenomic snapshot of the pleural effusion from 45 empyema patients by Illumina sequencing platform to assess its taxonomic, and antibiotic resistome structure. Our results showed that the variation of microbiota in the pleural effusion is generally stratified, not continuous. There are two distinct microbiome clusters observed in the forty-five samples: HA-SA type and LA-SA type. The categorization is mostly driven by species composition: HA-SA type is marked by

Indexed as

Empyema, PleuralMicrobiotaAnti-Bacterial AgentsBacteriaDrug Resistance, MicrobialHumansMetagenomicsAnti-Bacterial Agentscommunity structureempyemametagenomicmicrobiomeresistomeStaphylococcus aureus

Identifiers

PMID33796482
PMCPMC8008065
OpenAlexW3139523726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.